BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...from CFO to CEO. Philip Vickers joined Faze Medicines Inc. as CEO. He was president and CEO at Northern Biologics Inc. Launched...
BioCentury | Oct 30, 2020
Product Development

José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy

...company Mosaic Biomedicals S.L., which merged with Northern Biologics Inc....
BioCentury | May 14, 2020
Deals

With Northern Biologics deal, Boehringer adds pair of hot topics to its immuno-oncology basket

...an important but sparsely populated area of biology. The May 14 acquisition of Versant Ventures-built Northern Biologics Inc....
...into a five-year initiative to build its immuno-oncology pipeline. Boehringer Ingelheim GmbH’s takeout of the Northern Biologics...
...year of preclinical development. Versant’s Canadian success Northern Biologics’ CEO Vickers told BioCentury that Boehringer attracted Northern Biologics...
BioCentury | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

...membership. Oncology company Rgenix Inc. hired Robert Wasserman as CMO. Previously, he was CMO of Northern Biologics Inc....
BioCentury | Sep 11, 2019
Product Development

Pharmas’ challenge: learning from rare disease units while leaving them alone

...former global head of R&D at Shire from 2013-17 and now CEO of cancer company Northern Biologics Inc....
...said Curran. Senior Writer Allison Johnson contributed reporting for this story. Companies and Institutions Mentioned Northern Biologics Inc....
BioCentury | Aug 8, 2019
Distillery Therapeutics

LIF inhibition sensitizes pancreatic cancer to chemotherapy

...combination also reduced tumor growth in a patient-derived xenograft (PDX) mouse model of the disease. Northern Biologics Inc....
BioCentury | Jul 11, 2019
Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

...to respond to checkpoints,” said Joanne Hulme, VP and head of research at cancer company Northern Biologics Inc....
...pathways, and the contribution of each pathway may vary across different tumor types,” said English. Northern Biologics...
...Inc. (NYSE:MRK), Kenilworth, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland Northern Biologics Inc....
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...Hassan will become COO. Darlene Deptula-Hicks will succeed Hassan as CFO. She was CFO of Northern Biologics Inc....
BioCentury | Apr 17, 2019
Preclinical News

Salk study unveils LIF's mechanism in form of pancreatic cancer

...Studies pinpoints new mechanistic details about how LIF promotes pancreatic cancer, providing preclinical support for Northern Biologics'...
...adenocarcinoma (PDAC) progression and chemoresistance. Hunter is professor of molecular and cell biology at Salk. Northern Biologics Inc....
...its clinical trial. According to BioCentury's BCIQ database, Northern Biologics is the only company targeting LIF. Northern Biologics...
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...of cancer immunotherapy development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Immuno-oncology company Northern Biologics Inc....
Items per page:
1 - 10 of 28
BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...from CFO to CEO. Philip Vickers joined Faze Medicines Inc. as CEO. He was president and CEO at Northern Biologics Inc. Launched...
BioCentury | Oct 30, 2020
Product Development

José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy

...company Mosaic Biomedicals S.L., which merged with Northern Biologics Inc....
BioCentury | May 14, 2020
Deals

With Northern Biologics deal, Boehringer adds pair of hot topics to its immuno-oncology basket

...an important but sparsely populated area of biology. The May 14 acquisition of Versant Ventures-built Northern Biologics Inc....
...into a five-year initiative to build its immuno-oncology pipeline. Boehringer Ingelheim GmbH’s takeout of the Northern Biologics...
...year of preclinical development. Versant’s Canadian success Northern Biologics’ CEO Vickers told BioCentury that Boehringer attracted Northern Biologics...
BioCentury | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

...membership. Oncology company Rgenix Inc. hired Robert Wasserman as CMO. Previously, he was CMO of Northern Biologics Inc....
BioCentury | Sep 11, 2019
Product Development

Pharmas’ challenge: learning from rare disease units while leaving them alone

...former global head of R&D at Shire from 2013-17 and now CEO of cancer company Northern Biologics Inc....
...said Curran. Senior Writer Allison Johnson contributed reporting for this story. Companies and Institutions Mentioned Northern Biologics Inc....
BioCentury | Aug 8, 2019
Distillery Therapeutics

LIF inhibition sensitizes pancreatic cancer to chemotherapy

...combination also reduced tumor growth in a patient-derived xenograft (PDX) mouse model of the disease. Northern Biologics Inc....
BioCentury | Jul 11, 2019
Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

...to respond to checkpoints,” said Joanne Hulme, VP and head of research at cancer company Northern Biologics Inc....
...pathways, and the contribution of each pathway may vary across different tumor types,” said English. Northern Biologics...
...Inc. (NYSE:MRK), Kenilworth, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland Northern Biologics Inc....
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...Hassan will become COO. Darlene Deptula-Hicks will succeed Hassan as CFO. She was CFO of Northern Biologics Inc....
BioCentury | Apr 17, 2019
Preclinical News

Salk study unveils LIF's mechanism in form of pancreatic cancer

...Studies pinpoints new mechanistic details about how LIF promotes pancreatic cancer, providing preclinical support for Northern Biologics'...
...adenocarcinoma (PDAC) progression and chemoresistance. Hunter is professor of molecular and cell biology at Salk. Northern Biologics Inc....
...its clinical trial. According to BioCentury's BCIQ database, Northern Biologics is the only company targeting LIF. Northern Biologics...
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...of cancer immunotherapy development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Immuno-oncology company Northern Biologics Inc....
Items per page:
1 - 10 of 28